NI
Aptorum Group Limited
NIKI · NASDAQ
$5.25 +0.29% (+$0.02)
1M -41.07%
Market Cap $427.1K
P/E Ratio -
Div. Yield -
ROE 6.06%
Bulios Fair Price
$6.33
20.7% upside
Current Price
$5.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NIKI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.02x
EV/FFO N/A
P/S N/A
Growth
99 /100
Growing Book val. growth 13.73%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 6.06%
ROA 7.29%
Asset turnover 0.00x
Debt
75 /100
Low Current ratio 0.78x
Debt/Equity 0.15x
Net debt/EBITDA N/A
Stability
12 /100
Unstable EPS volatility 59.10%
Profitable years 0
Beta 0.17x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NIKI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chung Yuen Huen
Employees
1
Headquarters
Princeton